> It does imply AMPA antagonists or NAMs might be of interest to people with this problem, though
It does not necessarily.
For example, if the increased AMPA density is a counter-regulatory response to reduced baseline AMPA activation, further antagonizing the receptor system would worsen rather than improve the situation.
